<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02351089</url>
  </required_header>
  <id_info>
    <org_study_id>ProRad</org_study_id>
    <nct_id>NCT02351089</nct_id>
  </id_info>
  <brief_title>Probiotics in Radiation-treated Gynecologic Cancer</brief_title>
  <acronym>ProRad</acronym>
  <official_title>Probiotics in Radiation-treated Gynecologic Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Probi AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Probi AB</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current Project is to study the efficacy of a probiotic Product in reducing
      the symptoms of gastrointestinal toxicity linked to the irradiation of gynecologic cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in incidence of loose/watery stools</measure>
    <time_frame>Baseline and 10 weeks later</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gastrointestinal Toxicity</condition>
  <condition>Gynecologic Cancer</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>capsules containing corn starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic low dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>capsules containing probiotic powder and corn starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic high dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>capsules containing probiotic powder and corn starch</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Capsules placebo</intervention_name>
    <description>Capsules</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Capsules probiotic powder and corn starch</intervention_name>
    <arm_group_label>Probiotic low dose</arm_group_label>
    <arm_group_label>Probiotic high dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women diagnosed with cancer in the small pelvis and waiting to receive radiotherapy
             either as a primary or as a secondary treatment following surgery. Chemotherapy may or
             may not be part of the treatment regimen.

          -  Age, older than 18 years old.

          -  Agreement for participation in the study by signed written informed consent.

        Exclusion Criteria:

          -  Previously treated with irradiation of the pelvic area.

          -  Reluctance to refrain from using other probiotic products during the participation in
             the study.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria Bjurberg, MD, PhD</last_name>
    <email>maria.bjurberg@skane.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dept of Oncology</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Bjurberg</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2015</study_first_submitted>
  <study_first_submitted_qc>January 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2015</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

